495 related articles for article (PubMed ID: 15249690)
1. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
2. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
3. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
[TBL] [Abstract][Full Text] [Related]
4. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
[TBL] [Abstract][Full Text] [Related]
5. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
6. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
Ohkura S; Stoye JP
J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ; Aiken C
PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
[TBL] [Abstract][Full Text] [Related]
8. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
9. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
Carthagena L; Parise MC; Ringeard M; Chelbi-Alix MK; Hazan U; Nisole S
Retrovirology; 2008 Jul; 5():59. PubMed ID: 18613956
[TBL] [Abstract][Full Text] [Related]
10. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
Keckesova Z; Ylinen LM; Towers GJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10780-5. PubMed ID: 15249687
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
12. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
[TBL] [Abstract][Full Text] [Related]
14. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z; Ylinen LM; Towers GJ
J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
[TBL] [Abstract][Full Text] [Related]
16. Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction.
Maillard PV; Zoete V; Michielin O; Trono D
J Biol Chem; 2011 Mar; 286(10):8128-8140. PubMed ID: 21169362
[TBL] [Abstract][Full Text] [Related]
17. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
18. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
[TBL] [Abstract][Full Text] [Related]
19. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
[TBL] [Abstract][Full Text] [Related]
20. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
Kim J; Tipper C; Sodroski J
J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
